Best At-Home Nail Fungus Laser Therapy 2026: FungaBeam LLLT Device Featured in Consumer Education Report on Safety, Technology, and Realistic Expectations

Best At-Home Nail Fungus Laser Therapy 2026: FungaBeam LLLT Device Featured in Consumer Education Report on Safety, Technology, and Realistic Expectations Report provides LLLT technology education, safety considerations, and realistic timeline guidance for consumers evaluating FungaBeam and at-home nail fungus laser devices during January wellness planning season GlobeNewswire January 13, 2026 SCOTTSDALE, AZ, Jan. 13, […]

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

(NASDAQ:XTLB),(TASE:XTLB.TA),(NASDAQ:XAIR), Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying therapies exist FDA Orphan Drug designations secured for autism-related Phelan-McDermid Syndrome (PMS) and Glioblastoma Platform targets the core biology of autism, not just symptomatic relief Beyond

ACP CreativIT Unifies under New National Brand: Tusker

Five Regional Firms Acquired Since 2017; Additional Acquisitions Planned ACP CreativIT, a full-service technology solutions provider formed through the strategic acquisition of five highly regarded regional firms, today announced a rebrand unifying all offices under the name Tusker. The new brand identity sets the stage for future acquisitions and reflects the firm's proven strengths in

Euro Manganese Provides Update on Board of Directors

Vancouver, British Columbia–(Newsfile Corp. – January 13, 2026) –   Euro Manganese Inc. (TSXV: EMN) (ASX: EMN) (FSE: E060) (the “Company“, “Euro Manganese” or “EMN“) announces changes to its Board of Directors (the “Board“). Mr. John Webster has tendered his resignation as Director of the Company, effective January 13, 2026. Mr. Webster has served on

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership GlobeNewswire January 13, 2026 Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying therapies exist FDA Orphan Drug designations secured

All the Things They Carry: Exhibition opening 29 January 2026 at La Galerie des Photographes, Paris

The exhibition Toutes les choses qu’elles portent (All the Things They Carry) brings together four female artists whose works question what women continue to carry today: visible and invisible burdens, symbolic legacies, social constraints, and intimate experiences. Against a backdrop of weakening women’s rights, it explores the tension between creation, motherhood, and individuation: how to

Performance Shipping Inc. Announces Successful Placement of USD 50 Million Tap Issue

(NASDAQ:PSHG), ATHENS, Greece, Jan. 13, 2026 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG) (“we” or the “Company”), a global shipping company specializing in the ownership of tanker vessels, announced that it has successfully placed a USD 50 million tap issue in its outstanding senior secured bond due July 17, 2029, with ISIN: NO0013607028 (the

Performance Shipping Inc. Announces Successful Placement of USD 50 Million Tap Issue

Performance Shipping Inc. Announces Successful Placement of USD 50 Million Tap Issue GlobeNewswire January 13, 2026 ATHENS, Greece, Jan. 13, 2026 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG) (“we” or the “Company”), a global shipping company specializing in the ownership of tanker vessels, announced that it has successfully placed a USD 50 million tap

SMX Applies Molecular Tracking Technology to Silver Supply Chains

NEW YORK, NY / ACCESS Newswire / January 13, 2026 / SMX (NASDAQ:SMX)(NASDAQ:SMXWW), a leader in material-embedded identity and digital traceability solutions, is applying its proprietary molecular marking technology to silver, demonstrating how the metal can carry a persistent, verifiable identity throughout its lifecycle from production and refinement through use, resale, and recycling. Silver plays

AppYea Enters Commercial Execution Phase with Appointment of Techlott Founder Mark Katzenelson as President and Board Member

AppYea, Inc. (OTCQB: APYP) (“AppYea” or the “Company”) today announced a key leadership appointment supporting its ultimate transition into commercial execution and institutional deployment. Mark Katzenelson, Founder of Techlott and architect of the Company’s core blockchain technology, has been appointed President of AppYea and elected to its Board of Directors. The appointment follows the recent

Scroll to Top